RESUMEN
Liver cancer is a malignant tumor that develops on or inside the liver. Hedyotis diffusa Willd (HDW) plays a significant role in anti-tumor activities; however, its mechanism against liver cancer remains unclear. This study aims to evaluate the immunotherapeutic mechanism of HDW in treating liver cancer through network pharmacology, bioinformatics analysis, and experimental validation. Network pharmacology was utilized to identify the active components and potential targets of HDW from the TCMSP database. A potential target protein-protein interaction (PPI) network was constructed using the STRING database, followed by function and pathway enrichment analysis of the targets using GO and KEGG methods. In addition, the key targets for HDW against liver cancer were identified using five different algorithms in Cytoscape. The TCGA and HPA databases were used to assess the mRNA and protein expression of core target genes in normal liver and liver cancer tissues and their relationship with overall survival in liver cancer, as well as their role in immune infiltration. Molecular docking between the core components of HDW and the core targets was performed using PyMOL software. The effects of HDW on the proliferation and apoptosis of liver cancer cells were examined using MTT and flow cytometry. The regulatory effects of the core component quercetin on core targets were validated using RT-qPCR and Western blot. A total of 163 potential targets were identified by searching for intersections among 7 types of active components and all potential and liver cancer targets. PPI network analysis revealed the core targets IL6 and TNF. GO enrichment analysis involved 2089 biological processes, 76 cellular components, and 196 molecular functions. KEGG enrichment analysis suggested that the anti-cancer effects of HDW might be mediated by the AGE-RAGE signaling pathway, IL-17 signaling pathway, TNF signaling pathway, PI3K-Akt signaling pathway, and NF-κB signaling pathway. Database validation of key targets showed that mRNA and protein expression results for the IL6 gene were contradictory, while those for the TNF gene were consistent, both being underexpressed in liver cancer. Importantly, the expression of IL6 and TNF was related to the infiltration of 24 types of immune cells, with the highest correlation with macrophages. Molecular docking showed that IL6 and TNF had high binding stability with quercetin, with binding energies of - 7.4 and - 6.0 kJâmol-1, respectively. Experimental validation showed that quercetin inhibited liver cancer cell proliferation and promoted apoptosis in a dose-dependent manner, with protein results indicating that quercetin downregulated the mRNA and protein expression of IL6 and TNF, and upregulated key proteins in the AGE-RAGE signaling pathway, AGEs, and RAGE. This study comprehensively elucidates the activity, potential targets, and molecular mechanisms of HDW against liver cancer, providing a promising strategy for the scientific basis and treatment mechanism of traditional Chinese medicine in treating liver cancer.
RESUMEN
BACKGROUND AND OBJECTIVE: Magnetic resonance imaging (MRI), an advanced non-invasive technique, is regarded as one of the potential modalities in the diagnosis of breast cancer. This study was to investigate the application of dynamic contrast enhancement MRI and 3D reconstruction images in diagnosing breast tumors. METHODS: From May 2006 to September 2007, 30 patients with breast diseases were scanned with MRI in Sun Yat-sen University Cancer Center. MR plain scans, dynamic contrast enhancement scans were performed, and 3D reconstruction images were obtained. The normal breast tissue was used as control, and the maximum slope ratio was calculated. RESULTS: Forty-nine lesions were found in 30 patients, with an accuracy rate of 93.3%. CONCLUSION: MRI scan is an effective and specific modality for the diagnosis of breast diseases with high sensitivity and accuracy. Dynamic contrast enhancement MRI, image subtraction, time-signal intensity curve, 3D reconstruction images and the maximum slope ratio are helpful to make the correct diagnosis of breast lesions.
Asunto(s)
Neoplasias de la Mama/diagnóstico , Carcinoma Ductal de Mama/diagnóstico , Aumento de la Imagen , Imagenología Tridimensional , Imagen por Resonancia Magnética/métodos , Adulto , Anciano , Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/patología , Femenino , Fibroadenoma/diagnóstico , Fibroadenoma/patología , Humanos , Metástasis Linfática , Persona de Mediana Edad , Sensibilidad y Especificidad , Técnica de SustracciónRESUMEN
BACKGROUND & OBJECTIVE: Medical imaging-guided 125I radioactive seed implantation is a new method of mini-invasive therapy. As a component of combined therapy for malignant tumors, 125I implantation has benefits of minimal invasion, accurate position fixing, and certain clinical effects, and has been widely applied to treat tumors at present. Also the environmental phototoxis and radiation protection have been highly regarded. This study was to investigate the environmental radiation dose monitor after 125I radioactive seed implantation. METHODS: From Oct. 2004 to Dec. 2005, 20 patients with malignant tumors were randomly selected in this study after 125I radioactive seed implantation. Environmental radiation dose was detected right after operation and 2, 4 and 6 months later with gamma-ray equipment. RESULTS: With the increase of the distance from radioactive source, the radiation dose decreased quickly. The detected dose was close to a natural background radiation dose at a distance of 50 cm from radioactive source. With time passing, the environmental radiation dose was attenuated and the detected dose was close to natural background after 6 months. CONCLUSIONS: Addition to the isolation and shielding protection before and after 125I radioactive seed implantation, distance protection and time protection should be considered. With necessary strict protection, 125I implantation is safe to patients and environment.